首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level
【24h】

Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level

机译:异位miR-101对非小细胞肺癌细胞的放射增敏作用取决于内源性miR-101的水平

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Previously, we showed that ectopic miR-101 could sensitize human tumor cells to radiation by targeting ATM and DNA-PK catalytic subunit (DNA-PKcs) to inhibit DNA repair, as the endogenous miR-101 levels are low in tumors in general. However, the heterogeneity of human cancers may result in an exception. The purpose of this study was to test the hypothesis that a few tumor cell lines with a high level of endogenous miR-101 would prove less response to ectopic miR-101. Methods and Materials: Fourteeen non-small-cell lung cancer (NSCLC) cell lines and one immortalized non-malignant lung epithelial cell line (NL20) were used for comparing endogenous miR-101 levels by real-time reverse transcription-polymerase chain reaction. Based on the different miR-101 levels, four cell lines with different miR-101 levels were chosen for transfection with a green fluorescent protein-lentiviral plasmid encoding miR-101. The target protein levels were measured by using Western blotting. The radiosensitizing effects of ectopic miR-101 on these NSCLC cell lines were determined by a clonogenic assay and xenograft mouse model. Results: The endogenous miR-101 level was similar or lower in 13 NSCLC cell lines but was 11-fold higher in one cell line (H157) than in NL20 cells. Although ectopic miR-101 efficiently decreased the ATM and DNA-PKcs levels and increased the radiosensitization level in H1299, H1975, and A549 cells, it did not change the levels of the miR-101 targets or radiosensitivity in H157 cells. Similar results were observed in xenograft mice. Conclusions: A small number of NSCLC cell lines could have a high level of endogenous miR-101. The ectopic miR-101 was able to radiosensitize most NSCLC cells, except for the NSCLC cell lines that had a much higher endogenous miR-101 level. These results suggest that when we choose one miRNA as a therapeutic tool, the endogenous level of the miRNA in each tumor should be considered.
机译:目的:以前,我们显示异位miR-101可以通过靶向ATM和DNA-PK催化亚基(DNA-PKcs)抑制DNA修复来使人类肿瘤细胞对辐射敏感,因为一般而言,肿瘤中的内源性miR-101水平较低。但是,人类癌症的异质性可能会导致例外。这项研究的目的是检验以下假设:少数具有高水平内源性miR-101的肿瘤细胞系将证明对异位miR-101的反应较少。方法和材料:采用Fourteeen非小细胞肺癌(NSCLC)细胞系和一种永生化非恶性肺上皮细胞系(NL20),通过实时逆转录聚合酶链反应比较内源性miR-101水平。基于不同的miR-101水平,选择了具有不同miR-101水平的四个细胞系,以用编码miR-101的绿色荧光蛋白-慢病毒质粒转染。使用蛋白质印迹法测量目标蛋白水平。通过克隆形成试验和异种移植小鼠模型确定异位miR-101对这些NSCLC细胞系的放射增敏作用。结果:13种NSCLC细胞系中的内源性miR-101水平相似或更低,但一种细胞系(H157)中的内源性miR-101水平比NL20细胞高11倍。尽管异位miR-101有效地降低了H1299,H1975和A549细胞的ATM和DNA-PKcs水平并提高了放射增敏水平,但它并未改变miR-101靶标的水平或H157细胞中的放射敏感性。在异种移植小鼠中观察到相似的结果。结论:少数NSCLC细胞系可能具有高水平的内源性miR-101。异位miR-101能够使大多数NSCLC细胞放射增敏,但内源性miR-101水平较高的NSCLC细胞系除外。这些结果表明,当我们选择一种miRNA作为治疗工具时,应考虑每种肿瘤中miRNA的内源性水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号